Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05082402 · ClinicalTrials.gov registry record · NA

Imaging of Retinochoroidal Vasculature in Patients Being Assessed for Cardiovascular Disease

A NA study of Cardiovascular Diseases and Retina; Change, sponsored by Northwestern University.

Recruiting
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT05082402 is a NA study of Cardiovascular Diseases and Retina; Change that is actively recruiting participants, run by Northwestern University. The registered enrollment target is 50 participants, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05082402, a NA study of Cardiovascular Diseases and Retina; Change, is actively recruiting participants, sponsored by Northwestern University.

RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

This study aims to determine whether changes in retinal vasculature seen on SS-OCTA can be correlated to degree of cardiovascular disease as measured by carotid duplex ultrasonography.

Interventions

  • DIAGNOSTIC_TEST Swept Source Optical Coherence Tomography Angiography

Study Locations (1)

Illinois

  • Northwestern University/Northwestern Medical Group, Department of Ophthalmology - Chicago

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2021-08-17
Est. Completion 2024-12-31
Phase NA

Sponsor

Northwestern University

1,209 total trials

What the Registry Record Tells You About NCT05082402

The ClinicalTrials.gov registry entry for NCT05082402 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (100% lower). The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Cardiovascular Diseases appearing as the primary indexed condition, and to 1 intervention - of which Swept Source Optical Coherence Tomography Angiography is the first listed.

NCT05082402 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT05082402 about?

NCT05082402 is a clinical study titled "Imaging of Retinochoroidal Vasculature in Patients Being Assessed for Cardiovascular Disease". This study aims to determine whether changes in retinal vasculature seen on SS-OCTA can be correlated to degree of cardiovascular disease as measured by carotid duplex ultrasonography.

What is the current status of trial NCT05082402?

This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2021-08-17. Estimated completion is 2024-12-31.

What conditions does trial NCT05082402 study?

This clinical trial studies the following conditions: Cardiovascular Diseases, Retina; Change.

What interventions are being tested in trial NCT05082402?

The interventions under investigation include: Swept Source Optical Coherence Tomography Angiography (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT05082402?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05082402 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cardiovascular Diseases

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.